BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38334007)

  • 1. HTRA1 promotes EMT through the HDAC6/Ac-α-tubulin pathway in human GBM cells.
    Zhao W; Wu Y; Wang S; Zhao F; Liu W; Xue Z; Zhang L; Wang J; Han M; Li X; Huang B
    CNS Neurosci Ther; 2024 Feb; 30(2):e14605. PubMed ID: 38334007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of histone deacetylase 6 destabilizes ERK phosphorylation and suppresses cancer proliferation via modulation of the tubulin acetylation-GRP78 interaction.
    Wattanathamsan O; Chantaravisoot N; Wongkongkathep P; Kungsukool S; Chetprayoon P; Chanvorachote P; Vinayanuwattikun C; Pongrakhananon V
    J Biomed Sci; 2023 Jan; 30(1):4. PubMed ID: 36639650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IIp45 inhibits cell migration through inhibition of HDAC6.
    Wu Y; Song SW; Sun J; Bruner JM; Fuller GN; Zhang W
    J Biol Chem; 2010 Feb; 285(6):3554-3560. PubMed ID: 20008322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-22-3p inhibits fibrotic cataract through inactivation of HDAC6 and increase of α-tubulin acetylation.
    Wang X; Wang L; Sun Y; Chen B; Xiong L; Chen J; Huang M; Wu J; Tan X; Zheng Y; Huang S; Liu Y
    Cell Prolif; 2020 Nov; 53(11):e12911. PubMed ID: 32985730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of HDAC6 activity through interaction with RanBPM and its associated CTLH complex.
    Salemi LM; Maitland MER; Yefet ER; Schild-Poulter C
    BMC Cancer; 2017 Jul; 17(1):460. PubMed ID: 28668087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silence of HDAC6 suppressed esophageal squamous cell carcinoma proliferation and migration by disrupting chaperone function of HSP90.
    Tao H; Chen YY; Sun ZW; Chen HL; Chen M
    J Cell Biochem; 2018 Aug; 119(8):6623-6632. PubMed ID: 29665050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SECTM1 promotes the development of glioblastoma and mesenchymal transition by regulating the TGFβ1/Smad signaling pathway.
    Yao Z; Zhang F; Qi C; Wang C; Mao M; Zhao C; Qi M; Wang Z; Zhou G; Jiang X; Xia H
    Int J Biol Sci; 2024; 20(1):78-93. PubMed ID: 38164182
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of cell migration and induction of apoptosis by a novel class II histone deacetylase inhibitor, MCC2344.
    Dawood M; Fleischer E; Klinger A; Bringmann G; Shan L; Efferth T
    Pharmacol Res; 2020 Oct; 160():105076. PubMed ID: 32659428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDAC6 inhibition suppresses chondrosarcoma by restoring the expression of primary cilia.
    Xiang W; Guo F; Cheng W; Zhang J; Huang J; Wang R; Ma Z; Xu K
    Oncol Rep; 2017 Jul; 38(1):229-236. PubMed ID: 28586053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PSMA2 promotes glioma proliferation and migration via EMT.
    Zhang Y; Xiang Z; Chen L; Deng X; Liu H; Peng X
    Pathol Res Pract; 2024 Apr; 256():155278. PubMed ID: 38574629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Echinacoside (ECH) suppresses proliferation, migration, and invasion of human glioblastoma cells by inhibiting Skp2-triggered epithelial-mesenchymal transition (EMT).
    Shi S; Qin Y; Chen D; Deng Y; Yin J; Liu S; Yu H; Huang H; Chen C; Wu Y; Zou D; Wang Z
    Eur J Pharmacol; 2022 Oct; 932():175176. PubMed ID: 35995211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microrchidia family CW‑type zinc finger 2 promotes the proliferation, invasion, migration and epithelial‑mesenchymal transition of glioma by regulating PTEN/PI3K/AKT signaling via binding to N‑myc downstream regulated gene 1 promoter.
    Zhang J; Yang Y; Dong Y; Liu C
    Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34913078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpressed HDAC8 in cervical cancer cells shows functional redundancy of tubulin deacetylation with HDAC6.
    Vanaja GR; Ramulu HG; Kalle AM
    Cell Commun Signal; 2018 May; 16(1):20. PubMed ID: 29716651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a novel HDAC/RXR/HtrA1 signaling axis as a novel target to overcome cisplatin resistance in human non-small cell lung cancer.
    Wang W; Zhao M; Cui L; Ren Y; Zhang J; Chen J; Jia L; Zhang J; Yang J; Chen G; Ashby CR; Wu C; Chen ZS; Wang L
    Mol Cancer; 2020 Sep; 19(1):134. PubMed ID: 32878625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MircoRNA-1275 promotes proliferation, invasion and migration of glioma cells via SERPINE1.
    Wu DM; Wang S; Wen X; Han XR; Wang YJ; Fan SH; Zhang ZF; Shan Q; Lu J; Zheng YL
    J Cell Mol Med; 2018 Oct; 22(10):4963-4974. PubMed ID: 30024092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. circKIF4A promotes tumorogenesis of glioma by targeting miR-139-3p to activate Wnt5a signaling.
    Huo LW; Wang YF; Bai XB; Zheng HL; Wang MD
    Mol Med; 2020 Apr; 26(1):29. PubMed ID: 32268875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas.
    Han MZ; Xu R; Xu YY; Zhang X; Ni SL; Huang B; Chen AJ; Wei YZ; Wang S; Li WJ; Zhang Q; Li G; Li XG; Wang J
    J Exp Clin Cancer Res; 2017 Nov; 36(1):155. PubMed ID: 29110682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA LINC00174 promotes glycolysis and tumor progression by regulating miR-152-3p/SLC2A1 axis in glioma.
    Shi J; Zhang Y; Qin B; Wang Y; Zhu X
    J Exp Clin Cancer Res; 2019 Sep; 38(1):395. PubMed ID: 31492194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCR4 increases in-vivo glioma perivascular invasion, and reduces radiation induced apoptosis: A genetic knockdown study.
    Yadav VN; Zamler D; Baker GJ; Kadiyala P; Erdreich-Epstein A; DeCarvalho AC; Mikkelsen T; Castro MG; Lowenstein PR
    Oncotarget; 2016 Dec; 7(50):83701-83719. PubMed ID: 27863376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GLI2 promotes cell proliferation and migration through transcriptional activation of ARHGEF16 in human glioma cells.
    Huang D; Wang Y; Xu L; Chen L; Cheng M; Shi W; Xiong H; Zalli D; Luo S
    J Exp Clin Cancer Res; 2018 Oct; 37(1):247. PubMed ID: 30305138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.